Articles
Driving Commercial Excellence for CAR-T
Faruk Abdullah, Head of U.S. Consulting, EVERSANA™ MANAGEMENT CONSULTING and Maria Kirsch, SVP & Head of Patient Services share insight on building the future commercialization model designed specifically for CAR-T.
Insights from Clients: Shorla Pharma emphasizes how specialty pharmacy is streamlining commercialization in an unpredictable market and maximizing brand value in the oncology space through valuable partnership.
Shorla Pharma emphasizes how specialty pharmacy is streamlining commercialization in an unpredictable market and maximizing brand value in the oncology space through valuable partnership. Watch the full interview with Bio Europe and Sharon Cunningham, CEO,…
Insights from a CCO: Evolving oncology market dynamics and expediting therapy to metastatic HER2-positive breast cancer patients
Oncology Chief Commercialization Officer, Suzanne Greenwood, shares insights on evolving oncology market dynamics and expediting therapy to metastatic HER2-positive breast cancer patients Watch the full 60-minute virtual panel, “Next Gen Commercial Models in Oncology,” PharmaVOICE Editor Taren Grom…
A scorecard for osteoporosis in Canada and seven Canadian provinces
- Journal/Conference:
- Osteoporosis International
- Author(s):
- DL Kendler, JD Adachi, JP Brown, AG Juby, CS Kovacs, C Duperrouzel, RK McTavish, C Cameron, L Slatkovska, N Burke
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Skeletal
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
- Journal/Conference:
- Current Medical Research and Opinion
- Author(s):
- Samjoo IA, Worthington E, Haltner A, Spin P, Drudge C, Cameron C, Brennan R, Dahlke F, Adlard N
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Multiple Sclerosis, Nervous System
Using Survey Research to Develop Payer Strategies for an Existing Biologic’s Unique Indication in a Highly Competitive Market
How Pre-Launch Financial Exposure Modeling and Planning Can Help a Biopharmaceutical Reach More Patients
Developing a Channel Strategy Through Benchmarking For a First-in-Class Product Portfolio
European Guidelines and Real-World Evidence of Maintenance Treatments for Adults with Acute Myeloid Leukemia in First Complete Remission.
- Journal/Conference:
- European Hematology Association Annual Meeting
- Author(s):
- Ahmed M, Thompson G, Martin C, Cameron H, Chen C
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy.
- Journal/Conference:
- Blood 138 (Supplement 1): 3015
- Author(s):
- Chen, C.; Huls, GA.; Cameron, H.; Suero, B.; Vasconcelos A.; Gaugler, L.; Beach, C.L.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology